Targeting CXCR4 with cell-penetrating pepducins in lymphoma and lymphocytic leukemia
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting CXCR4 with cell-penetrating pepducins in lymphoma and lymphocytic leukemia
Authors
Keywords
-
Journal
BLOOD
Volume 119, Issue 7, Pages 1717-1725
Publisher
American Society of Hematology
Online
2011-12-21
DOI
10.1182/blood-2011-04-347518
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting Protease-Activated Receptor-1 with Cell-Penetrating Pepducins in Lung Cancer
- (2011) Jaroslaw Cisowski et al. AMERICAN JOURNAL OF PATHOLOGY
- Bortezomib modulates surface CD20 in B-cell malignancies and affects rituximab-mediated complement-dependent cytotoxicity
- (2010) J. Bil et al. BLOOD
- Pan-histone deacetylase inhibitor panobinostat depletes CXCR4 levels and signaling and exerts synergistic antimyeloid activity in combination with CXCR4 antagonists
- (2010) A. Mandawat et al. BLOOD
- The microenvironment differentially impairs passive and active immunotherapy in chronic lymphocytic leukaemia - CXCR4 antagonists as potential adjuvants for monoclonal antibodies
- (2010) Maike Buchner et al. BRITISH JOURNAL OF HAEMATOLOGY
- Identification of a Metalloprotease-Chemokine Signaling System in the Ovarian Cancer Microenvironment: Implications for Antiangiogenic Therapy
- (2010) A. Agarwal et al. CANCER RESEARCH
- Rituximab
- (2010) Gillian M. Keating DRUGS
- The Peptidomimetic CXCR4 Antagonist TC14012 Recruits β-Arrestin to CXCR7
- (2010) Stéphanie Gravel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery of a CXCR4 agonist pepducin that mobilizes bone marrow hematopoietic cells
- (2010) B. Tchernychev et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy
- (2009) A. K. Azab et al. BLOOD
- Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance
- (2009) A. V. Kurtova et al. BLOOD
- Cytoplasmic CXCR4 expression in breast cancer: induction by nitric oxide and correlation with lymph node metastasis and poor prognosis
- (2009) Hironao Yasuoka et al. BMC CANCER
- Blockade of PAR1 Signaling with Cell-Penetrating Pepducins Inhibits Akt Survival Pathways in Breast Cancer Cells and Suppresses Tumor Survival and Metastasis
- (2009) E. Yang et al. CANCER RESEARCH
- Platelet Matrix Metalloprotease-1 Mediates Thrombogenesis by Activating PAR1 at a Cryptic Ligand Site
- (2009) Vishal Trivedi et al. CELL
- AMD3100 Is a CXCR7 Ligand with Allosteric Agonist Properties
- (2009) I. Kalatskaya et al. MOLECULAR PHARMACOLOGY
- Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML
- (2008) Z. Zeng et al. BLOOD
- Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer
- (2008) A. Agarwal et al. MOLECULAR CANCER THERAPEUTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now